SAN DIEGO — It is an unusual time to be in the vaccine business. But in the view of those gathered here at the BIO international conference this week, it’s not altogether a bleak one.
In fact, some vaccine makers are feeling more optimistic than they were a year ago — considering the circumstances, at least.
In interviews with STAT, they acknowledged that Health Secretary Robert F. Kennedy Jr., a longtime vaccine critic, has brought once-unthinkable disruptions — the cancellation of major mRNA vaccine contracts, the dismantling of universal vaccine recommendations, cuts to government funding for research — and that Washington could deliver more ahead.
